SOLAND DANIEL B

CIK 00013184856 companiesEXTON, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001318485

Recent Transactions

50 trades

Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29−9,387→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2025-05-29+13,793→ 13,793 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29+8,107→ 8,107 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-29+9,387→ 44,041 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-29+6,652→ 34,654 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29+9,387→ 9,387 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2024-05-29+15,959→ 15,959 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29−6,652→ 0 total
Purchase
DBV Technologies S.A.$DBVT
Ordinary Shares
2023-08-01$1.62/sh+15,000→ 20,000 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-06-01+8,552→ 28,002 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2023-06-01+11,045→ 11,045 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01+6,652→ 6,652 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01−8,552→ 0 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-07-06+66,500→ 66,500 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-06-07−6,391→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-06-07+8,552→ 8,552 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2022-06-07+6,391→ 19,450 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2022-06-07+14,368→ 14,368 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-04-01+41,500→ 41,500 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-01-24+25,000→ 25,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2021-09-30+10,000→ 10,000 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2021-07-08+66,500→ 66,500 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2021-06-22+11,637→ 11,637 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2021-06-22+6,391→ 6,391 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2021-06-22+3,059→ 13,059 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2021-06-22−3,059→ 0 total
Purchase
Aceragen, Inc.
Common Stock
2021-06-18$1.19/sh+50,000→ 78,843 total
Purchase
DBV Technologies S.A.$DBVT
Warrant (right to buy)
2021-06-10$7.12/sh+6,837→ 6,837 total
Purchase
Aceragen, Inc.
Common Stock
2021-03-05$3.90/sh+10,000→ 28,843 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2021-01-04+200,000→ 200,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (right to buy)
2020-10-01+7,000→ 7,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (right to buy)
2020-10-01+7,000→ 7,000 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2020-06-23+5,579→ 5,579 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2020-06-23+3,059→ 3,059 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-09-27$11.87/sh+7,962→ 10,000 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-09-26$11.90/sh+2,038→ 2,038 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2019-06-26−22,500→ 22,500 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2019-04-22+14,000→ 14,000 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2018-06-06+15,000→ 15,000 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2018-06-06+15,000→ 15,000 total
Purchase
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2018-03-02$22.52/sh+3,000→ 10,000 total
Purchase
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2018-03-01$24.52/sh+2,000→ 7,000 total
Purchase
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2018-03-01$24.09/sh+3,000→ 5,000 total
Purchase
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2018-03-01$23.02/sh+2,000→ 2,000 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2017-07-17+15,000→ 15,000 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2017-06-13+15,000→ 15,000 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2016-06-10+12,500→ 12,500 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2015-06-15+12,500→ 12,500 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2015-03-20
Disposition from Tender
VIROPHARMA INC
Common Stock
2014-01-24$50.00/sh−153,332→ 0 total

Companies

Recent Filings

Address

730 STOCKTON DRIVE

EXTON, PA, 19341

View on SEC.gov